Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomohiro Aoki

Showing results (11-20 of 161) with videos related to

Pageof 17
Sort By:
Med (New York, N.Y.)|May 19, 2022
Cell-free DNA in Hodgkin Lymphoma: A future standard?Tomohiro Aoki, Christian Steidl
Trends in Pharmacological Sciences|April 3, 2012
Prostaglandins and chronic inflammationTomohiro Aoki, Shuh Narumiya
Expert Opinion on Therapeutic Targets|February 5, 2010
Targeting chronic inflammation in cerebral aneurysms: focusing on NF-kappaB as a putative target of medical therapyTomohiro Aoki, M Nishimura
Journal of Clinical Medicine|November 27, 2025
Mechanisms of Intracranial Aneurysm Rupture: An Integrative Review of Experimental and Clinical EvidenceMasahiko Itani, Tomohiro Aoki
Blood|December 22, 2022
Novel insights into Hodgkin lymphoma biology by single-cell analysisTomohiro Aoki, Christian Steidl
Journal of Biomedicine & Biotechnology|January 22, 2011
The development and the use of experimental animal models to study the underlying mechanisms of CA formationTomohiro Aoki, Masaki Nishimura
Inflammation and Regeneration|December 21, 2017
Prostaglandin E<sub>2</sub>-EP2 signaling as a node of chronic inflammation in the colon tumor microenvironmentTomohiro Aoki, Shuh Narumiya
No Shinkei Geka. Neurological Surgery|September 17, 2024
[Molecular Mechanisms Underlying Intracranial Aneurysm Rupture]Tomohiro Aoki, Masahiko Itani
Blood|April 9, 2026
Targeted therapy in early-stage classical Hodgkin lymphomaTomohiro Aoki, John Kuruvilla
Cellular & Molecular Immunology|July 21, 2015
Prostaglandin E2-EP4 signaling persistently amplifies CD40-mediated induction of IL-23 p19 expression through canonical and non-canonical NF-κB pathwaysXiaojun Ma, Tomohiro Aoki, Shuh Narumiya
Pageof 17

Showing results (11-20 of 161) with videos related to

Sort By:
Pageof 17
Med (New York, N.Y.)|May 19, 2022
Cell-free DNA in Hodgkin Lymphoma: A future standard?Tomohiro Aoki, Christian Steidl
Trends in Pharmacological Sciences|April 3, 2012
Prostaglandins and chronic inflammationTomohiro Aoki, Shuh Narumiya
Expert Opinion on Therapeutic Targets|February 5, 2010
Targeting chronic inflammation in cerebral aneurysms: focusing on NF-kappaB as a putative target of medical therapyTomohiro Aoki, M Nishimura
Journal of Clinical Medicine|November 27, 2025
Mechanisms of Intracranial Aneurysm Rupture: An Integrative Review of Experimental and Clinical EvidenceMasahiko Itani, Tomohiro Aoki
Blood|December 22, 2022
Novel insights into Hodgkin lymphoma biology by single-cell analysisTomohiro Aoki, Christian Steidl
Journal of Biomedicine & Biotechnology|January 22, 2011
The development and the use of experimental animal models to study the underlying mechanisms of CA formationTomohiro Aoki, Masaki Nishimura
Inflammation and Regeneration|December 21, 2017
Prostaglandin E<sub>2</sub>-EP2 signaling as a node of chronic inflammation in the colon tumor microenvironmentTomohiro Aoki, Shuh Narumiya
No Shinkei Geka. Neurological Surgery|September 17, 2024
[Molecular Mechanisms Underlying Intracranial Aneurysm Rupture]Tomohiro Aoki, Masahiko Itani
Blood|April 9, 2026
Targeted therapy in early-stage classical Hodgkin lymphomaTomohiro Aoki, John Kuruvilla
Cellular & Molecular Immunology|July 21, 2015
Prostaglandin E2-EP4 signaling persistently amplifies CD40-mediated induction of IL-23 p19 expression through canonical and non-canonical NF-κB pathwaysXiaojun Ma, Tomohiro Aoki, Shuh Narumiya
Pageof 17